Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Prognostic Potential of the Panfungal Marker (1 → 3)-β-D-Glucan in Invasive Mycoses Patients.

Pini P, Venturelli C, Girardis M, Forghieri F, Blasi E.

Mycopathologia. 2018 Jul 2. doi: 10.1007/s11046-018-0282-5. [Epub ahead of print]

PMID:
29967970
2.

Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells.

Bertacchini J, Frasson C, Chiarini F, D'Avella D, Accordi B, Anselmi L, Barozzi P, Forghieri F, Luppi M, Martelli AM, Basso G, Najmaldin S, Khosravi A, Rahim F, Marmiroli S.

Adv Biol Regul. 2018 May;68:2-9. doi: 10.1016/j.jbior.2018.03.001. Epub 2018 Mar 19.

PMID:
29576448
3.

Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study.

Nasillo V, Paolini A, Riva G, Morselli M, Potenza L, Coluccio V, Maccaferri M, Colaci E, Fantuzzi V, Messerotti A, Arletti L, Pioli V, Lugli E, Gilioli A, Quadrelli C, Zucchini P, Vallerini D, Lagreca I, Barozzi P, Cuoghi A, Bresciani P, Marasca R, Mariano MT, Ceccherelli G, Comoli P, Campioli D, Trenti T, Narni F, Luppi M, Forghieri F.

Leuk Lymphoma. 2018 Jan;59(1):225-228. doi: 10.1080/10428194.2017.1321748. Epub 2017 Jun 7. No abstract available.

PMID:
28587560
4.

Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.

Lazzarotto D, Candoni A, Filì C, Forghieri F, Pagano L, Busca A, Spinosa G, Zannier ME, Simeone E, Isola M, Borlenghi E, Melillo L, Mosna F, Lessi F, Fanin R.

Leuk Res. 2017 Feb;53:74-81. doi: 10.1016/j.leukres.2016.12.003. Epub 2016 Dec 20.

PMID:
28056398
5.

Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis.

Vallerini D, Forghieri F, Lagreca I, Riva G, Barozzi P, Quadrelli C, Morselli M, Bresciani P, Cuoghi A, Coluccio V, Maccaferri M, Paolini A, Colaci E, Marasca R, Narni F, Cellini M, Beauvais A, Latgè JP, Romani L, Iughetti L, Comoli P, Campioli D, Trenti T, Luppi M, Potenza L.

J Infect. 2017 Mar;74(3):314-318. doi: 10.1016/j.jinf.2016.12.008. Epub 2016 Dec 23. No abstract available.

PMID:
28017824
6.

All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature.

Forghieri F, Bigliardi S, Quadrelli C, Morselli M, Potenza L, Paolini A, Colaci E, Barozzi P, Zucchini P, Riva G, Vallerini D, Lagreca I, Marasca R, Narni F, Venditti A, Martelli MP, Falini B, Lo Coco F, Amadori S, Luppi M.

Clin Case Rep. 2016 Oct 24;4(12):1138-1146. eCollection 2016 Dec.

7.

BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.

Comoli P, Basso S, Riva G, Barozzi P, Guido I, Gurrado A, Quartuccio G, Rubert L, Lagreca I, Vallerini D, Forghieri F, Morselli M, Bresciani P, Cuoghi A, Paolini A, Colaci E, Marasca R, Cuneo A, Iughetti L, Trenti T, Narni F, Foà R, Zecca M, Luppi M, Potenza L.

Blood. 2017 Feb 2;129(5):582-586. doi: 10.1182/blood-2016-07-731091. Epub 2016 Dec 7.

8.

Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6.

Barozzi P, Riva G, Vallerini D, Quadrelli C, Lagreca I, Eccheli R, Forghieri F, Coluccio V, Maccaferri M, Paolini A, Colaci E, Morselli M, Marasca R, Narni F, Comoli P, Campioli D, Trenti T, Potenza L, Luppi M.

Clin Microbiol Infect. 2016 Oct;22(10):893-895. doi: 10.1016/j.cmi.2016.07.006. Epub 2016 Jul 9. No abstract available.

9.

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.

Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F, Borchiellini A, Carpenedo M, Simula MP, Di Giacomo V, Bergamaschi M, Vincelli ID, Rodeghiero F, Ruggeri M, Scaramucci L, Rambaldi A, Cascavilla N, Forghieri F, Petrungaro A, Ditonno P, Caocci G, Cirrincione S, Mazzucconi MG.

Am J Hematol. 2016 Oct;91(10):995-1001. doi: 10.1002/ajh.24463. Epub 2016 Jul 14.

10.

The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes.

Maccaferri M, Pierini V, Di Giacomo D, Zucchini P, Forghieri F, Bonacorsi G, Paolini A, Quadrelli C, Giacobbi F, Fontana F, Cappelli G, Potenza L, Marasca R, Luppi M, Mecucci C.

Leuk Lymphoma. 2017 Feb;58(2):489-493. Epub 2016 Jun 24. No abstract available.

PMID:
27337990
11.

Primary central nervous system diffuse large B-cell lymphoma (DLBCL) can rarely mimic an acute peripheral neuropathy.

Galassi G, Forghieri F, Malagoli M.

Muscle Nerve. 2016 Jun;53(6):995-6. doi: 10.1002/mus.25119. Epub 2016 Apr 25. No abstract available.

PMID:
27015282
12.

Mucorales-Specific T Cells in Patients with Hematologic Malignancies.

Potenza L, Vallerini D, Barozzi P, Riva G, Gilioli A, Forghieri F, Candoni A, Cesaro S, Quadrelli C, Maertens J, Rossi G, Morselli M, Codeluppi M, Mussini C, Colaci E, Messerotti A, Paolini A, Maccaferri M, Fantuzzi V, Del Giovane C, Stefani A, Morandi U, Maffei R, Marasca R, Narni F, Fanin R, Comoli P, Romani L, Beauvais A, Viale PL, Latgè JP, Lewis RE, Luppi M.

PLoS One. 2016 Feb 12;11(2):e0149108. doi: 10.1371/journal.pone.0149108. eCollection 2016.

13.

The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi.

Vallerini D, Riva G, Barozzi P, Forghieri F, Lagreca I, Quadrelli C, Morselli M, Bresciani P, Cuoghi A, Coluccio V, Maccaferri M, Paolini A, Colaci E, Marasca R, Narni F, Latgè JP, Romani L, Comoli P, Campioli D, Trenti T, Luppi M, Potenza L.

Med Mycol. 2016 Mar;54(3):327-32. doi: 10.1093/mmy/myv107. Epub 2015 Dec 24.

PMID:
26705835
14.

Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation.

Forghieri F, Luppi M, Barozzi P, Riva G, Morselli M, Bigliardi S, Quadrelli C, Vallerini D, Maccaferri M, Coluccio V, Paolini A, Colaci E, Bonacorsi G, Maiorana A, Tagliazucchi S, Rumpianesi F, Mattioli F, Presutti L, Gelmini R, Cermelli C, Rossi G, Comoli P, Marasca R, Narni F, Potenza L.

Br J Haematol. 2016 Feb;172(4):561-72. doi: 10.1111/bjh.13871. Epub 2015 Dec 18.

PMID:
26684692
15.

Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.

Forghieri F, Luppi M, Potenza L.

Hematology. 2015 Dec;20(10):618-9. doi: 10.1179/1024533215Z.000000000402. Review. No abstract available.

PMID:
26574786
16.

Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers.

Cojutti P, Candoni A, Forghieri F, Isola M, Zannier ME, Bigliardi S, Luppi M, Fanin R, Pea F.

Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):474-9. doi: 10.1111/bcpt.12530. Epub 2015 Dec 28.

17.

Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.

Pini P, Bettua C, Orsi CF, Venturelli C, Forghieri F, Bigliardi S, Faglioni L, Luppi F, Serio L, Codeluppi M, Luppi M, Mussini C, Girardis M, Blasi E.

Infection. 2016 Apr;44(2):223-33. doi: 10.1007/s15010-015-0849-8. Epub 2015 Oct 16.

PMID:
26475482
18.

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

Riva G, Lagreca I, Mattiolo A, Belletti D, Lignitto L, Barozzi P, Ruozi B, Vallerini D, Quadrelli C, Corradini G, Forghieri F, Marasca R, Narni F, Tosi G, Forni F, Vandelli MA, Amadori A, Chieco-Bianchi L, Potenza L, Calabrò ML, Luppi M.

Haematologica. 2015 Nov;100(11):e467-70. doi: 10.3324/haematol.2015.126854. Epub 2015 Jul 23. No abstract available.

19.

Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study.

Bigliardi S, Morselli M, Potenza L, Riva G, Coluccio V, Maccaferri M, Paolini A, Colaci E, Fantuzzi V, Soci F, Nasillo V, Messerotti A, Arletti L, Pioli V, Lugli E, Gilioli A, Quadrelli C, Vallerini D, Barozzi P, Lagreca I, Marasca R, Narni F, Franceschini E, Codeluppi M, Mussini C, Luppi M, Forghieri F.

Ann Hematol. 2015 Nov;94(11):1931-4. doi: 10.1007/s00277-015-2455-3. Epub 2015 Jul 25. No abstract available.

PMID:
26204825
20.

4q12 translocations with GSX2 expression identify a CD7(+) acute myeloid leukaemia subset.

Di Giacomo D, La Starza R, Barba G, Pierini V, Baldazzi C, Storlazzi CT, Daniele G, Forghieri F, Borlenghi E, Testoni N, Mecucci C.

Br J Haematol. 2015 Oct;171(1):141-5. doi: 10.1111/bjh.13368. Epub 2015 Mar 30. No abstract available.

PMID:
25816740
21.

NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.

Forghieri F, Paolini A, Morselli M, Bigliardi S, Bonacorsi G, Leonardi G, Coluccio V, Maccaferri M, Fantuzzi V, Faglioni L, Colaci E, Soci F, Nasillo V, Messerotti A, Arletti L, Pioli V, Zucchini P, Quadrelli C, Corradini G, Giacobbi F, Vallerini D, Riva G, Barozzi P, Lagreca I, Marasca R, Narni F, Mecucci C, Ottaviani E, Martinelli G, Falini B, Luppi M, Potenza L.

Leuk Lymphoma. 2015;56(11):3222-6. doi: 10.3109/10428194.2015.1026900. Epub 2015 May 12. Review. No abstract available.

PMID:
25813079
22.

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

Mosna F, Papayannidis C, Martinelli G, Di Bona E, Bonalumi A, Tecchio C, Candoni A, Capelli D, Piccin A, Forghieri F, Bigazzi C, Visani G, Zambello R, Zanatta L, Volpato F, Paolini S, Testoni N, Gherlinzoni F, Gottardi M.

Am J Hematol. 2015 Jun;90(6):515-23. doi: 10.1002/ajh.24000. Epub 2015 Apr 1.

23.

Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests.

Orsi CF, Bettua C, Pini P, Venturelli C, La Regina A, Morace G, Luppi M, Forghieri F, Bigliardi S, Luppi F, Codeluppi M, Girardis M, Blasi E.

New Microbiol. 2015 Jan;38(1):75-84. Epub 2015 Jan 1.

24.

Splenomegaly secondary to myeloproliferative neoplasms and portal hypertension.

Manenti A, Forghieri F, Colasanto D, MarioLuppi.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e135. doi: 10.1016/j.clml.2014.10.005. Epub 2014 Nov 6. No abstract available.

PMID:
25465464
25.

An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts.

Forghieri F, Bigliardi S, Morselli M, Potenza L, Fantuzzi V, Faglioni L, Nasillo V, Messerotti A, Paolini A, Luppi M.

Leuk Res Rep. 2014 Sep 30;3(2):83-5. doi: 10.1016/j.lrr.2014.09.003. eCollection 2014.

26.

Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay.

Pini P, Bettua C, Orsi CF, Venturelli C, Faglioni L, Forghieri F, Bigliardi S, Luppi F, Girardis M, Blasi E.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):131-136. doi: 10.1007/s10096-014-2211-y. Epub 2014 Aug 1.

PMID:
25082186
27.

Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study.

Bigliardi S, Morselli M, Potenza L, Coluccio V, Maccaferri M, Paolini A, Colaci E, Fantuzzi V, Faglioni L, Soci F, Nasillo V, Messerotti A, Pedrazzi P, Marietta M, Luppi M, Forghieri F.

Leuk Lymphoma. 2015 Mar;56(3):770-3. doi: 10.3109/10428194.2014.933216. Epub 2014 Aug 4. No abstract available.

PMID:
24991716
28.

EGN model of non-linear fiber propagation.

Carena A, Bosco G, Curri V, Jiang Y, Poggiolini P, Forghieri F.

Opt Express. 2014 Jun 30;22(13):16335-62. doi: 10.1364/OE.22.016335.

PMID:
24977884
29.

Splenomegaly in hematological malignancies and portal hypertension.

Manenti A, Forghieri F, Colasanto D, Luppi M.

Presse Med. 2014 Nov;43(11):1295-6. doi: 10.1016/j.lpm.2014.02.024. Epub 2014 Jun 13. No abstract available.

PMID:
24935684
30.

An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells?

Bigliardi S, Morselli M, Potenza L, Bresciani P, Cuoghi A, Coluccio V, Riva G, Paolini A, Fantuzzi V, Faglioni L, Nasillo V, Messerotti A, Marasca R, Narni F, Luppi M, Forghieri F.

Bone Marrow Transplant. 2014 Sep;49(9):1237-8. doi: 10.1038/bmt.2014.119. Epub 2014 Jun 2. No abstract available.

PMID:
24887386
31.

Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.

Bertacchini J, Guida M, Accordi B, Mediani L, Martelli AM, Barozzi P, Petricoin E 3rd, Liotta L, Milani G, Giordan M, Luppi M, Forghieri F, De Pol A, Cocco L, Basso G, Marmiroli S.

Leukemia. 2014 Nov;28(11):2197-205. doi: 10.1038/leu.2014.123. Epub 2014 Apr 4.

PMID:
24699302
32.

1306-km 20x124.8-Gb/s PM-64QAM transmission over PSCF with net SEDP 11,300 (b ∙ km)/s/Hz using 1.15 samp/symb DAC.

Nespola A, Straullu S, Bosco G, Carena A, Yanchao J, Poggiolini P, Forghieri F, Yamamoto Y, Hirano M, Sasaki T, Bauwelinck J, Verheyen K.

Opt Express. 2014 Jan 27;22(2):1796-805. doi: 10.1364/OE.22.001796.

PMID:
24515188
33.

Compatibility between coherent reflective burst-mode PON and TWDM-PON physical layers.

Straullu S, Forghieri F, Bosco G, Ferrero V, Gaudino R.

Opt Express. 2014 Jan 13;22(1):9-14. doi: 10.1364/OE.22.000009.

PMID:
24514959
34.

Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis.

Maccaferri M, Leonardi G, Marasca R, Colaci E, Paolini A, Soci F, Forghieri F, Potenza L, Narni F, Luppi M.

Leuk Lymphoma. 2014 Sep;55(9):2207-8. doi: 10.3109/10428194.2013.873538. Epub 2014 Jan 28. No abstract available.

PMID:
24354678
35.

Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.

Riva G, Luppi M, Lagreca I, Barozzi P, Quadrelli C, Vallerini D, Zanetti E, Basso S, Forghieri F, Morselli M, Maccaferri M, Paolini A, Fantuzzi V, Messerotti A, Maffei R, Iacobucci I, Martinelli G, Marasca R, Narni F, Comoli P, Potenza L.

Br J Haematol. 2014 Jan;164(2):299-302. doi: 10.1111/bjh.12612. Epub 2013 Oct 18. No abstract available.

PMID:
24134676
36.

Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients.

Potenza L, Vallerini D, Barozzi P, Riva G, Forghieri F, Beauvais A, Beau R, Candoni A, Maertens J, Rossi G, Morselli M, Zanetti E, Quadrelli C, Codeluppi M, Guaraldi G, Pagano L, Caira M, Del Giovane C, Maccaferri M, Stefani A, Morandi U, Tazzioli G, Girardis M, Delia M, Specchia G, Longo G, Marasca R, Narni F, Merli F, Imovilli A, Apolone G, Carvalho A, Comoli P, Romani L, Latgè JP, Luppi M.

PLoS One. 2013 Sep 4;8(9):e74326. doi: 10.1371/journal.pone.0074326. eCollection 2013.

37.

Human herpesvirus 8 (HHV8) infection and related diseases in Italian transplant cohorts.

Riva G, Barozzi P, Quadrelli C, Vallerini D, Zanetti E, Forghieri F, Chiereghin A, Libri I, Maggiore U, Buzio C, Lazzarotto T, Narni F, Luppi M, Potenza L.

Am J Transplant. 2013 Jun;13(6):1619-20. doi: 10.1111/ajt.12225. Epub 2013 Apr 22. No abstract available.

38.

Extension and validation of the GN model for non-linear interference to uncompensated links using Raman amplification.

Curri V, Carena A, Poggiolini P, Bosco G, Forghieri F.

Opt Express. 2013 Feb 11;21(3):3308-17. doi: 10.1364/OE.21.003308.

PMID:
23481790
39.

Optimization of self-coherent reflective PON to achieve a new record 42 dB ODN power budget after 100 km at 1.25 Gbps.

Straullu S, Forghieri F, Ferrero V, Gaudino R.

Opt Express. 2012 Dec 31;20(28):29590-8. doi: 10.1364/OE.20.029590.

PMID:
23388785
40.

Characterization of uncooled RSOA for upstream transmission in WDM reflective PONs.

Straullu S, Abrate S, Forghieri F, Rizzelli G, Ferrero V, Gaudino R.

Opt Express. 2012 Dec 10;20(26):B38-44. doi: 10.1364/OE.20.000B38.

PMID:
23262877
41.

Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy.

Grottola A, Forghieri F, Meacci M, Fabio A, Pozzi L, Marchegiano P, Codeluppi M, Morselli M, Potenza L, Paolini A, Coluccio V, Luppi M, Rumpianesi F, Pecorari M.

Emerg Infect Dis. 2012 Nov;18(11):1911-3. doi: 10.3201/eid1811.120216. No abstract available.

42.

How I treat HHV8/KSHV-related diseases in posttransplant patients.

Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L.

Blood. 2012 Nov 15;120(20):4150-9. doi: 10.1182/blood-2012-04-421412. Epub 2012 Sep 11.

43.

Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.

Forghieri F, Luppi M, Barozzi P, Maffei R, Potenza L, Narni F, Marasca R.

Clin Dev Immunol. 2012;2012:807351. doi: 10.1155/2012/807351. Epub 2012 Jul 11. Review.

44.

BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy.

Riva G, Luppi M, Quadrelli C, Barozzi P, Basso S, Vallerini D, Zanetti E, Morselli M, Forghieri F, Maccaferri M, Paolini A, Del Giovane C, D'Amico R, Marasca R, Narni F, Iacobucci I, Martinelli G, Baccarani M, Comoli P, Potenza L.

Blood Cancer J. 2011 Jul;1(7):e30. doi: 10.1038/bcj.2011.26. Epub 2011 Jul 22. No abstract available.

45.

Novel figure of merit to compare fibers in coherent detection systems with uncompensated links.

Carena A, Curri V, Bosco G, Cigliutti R, Torrengo E, Poggiolini P, Nespola A, Zeolla D, Forghieri F.

Opt Express. 2012 Jan 2;20(1):339-46. doi: 10.1364/OE.20.000339.

PMID:
22274357
46.

Experimental validation of an analytical model for nonlinear propagation in uncompensated optical links.

Torrengo E, Cigliutti R, Bosco G, Carena A, Curri V, Poggiolini P, Nespola A, Zeolla D, Forghieri F.

Opt Express. 2011 Dec 12;19(26):B790-8. doi: 10.1364/OE.19.00B790.

PMID:
22274104
47.

Analytical results on channel capacity in uncompensated optical links with coherent detection.

Bosco G, Poggiolini P, Carena A, Curri V, Forghieri F.

Opt Express. 2011 Dec 12;19(26):B438-49. doi: 10.1364/OE.19.00B440. Erratum in: Opt Express. 2012 Aug 13;20(17):19610-1.

PMID:
22274054
48.

Atraumatic splenic rupture in patients with myelodysplastic syndromes: report of a case occurred during treatment with 5-azacitidine and review of the literature.

Forghieri F, Morselli M, Leonardi G, Potenza L, Bonacorsi G, Coluccio V, Paolini A, Maccaferri M, Colaci E, Fantuzzi V, Bigliardi S, Zaldini P, Riva G, Barozzi P, Leonardi L, Rossi A, Marasca R, Narni F, Luppi M.

Leuk Res. 2012 Mar;36(3):e52-6. doi: 10.1016/j.leukres.2011.10.031. Epub 2011 Dec 14. Review. No abstract available.

PMID:
22172466
49.

β-HHVs and HHV-8 in Lymphoproliferative Disorders.

Quadrelli C, Barozzi P, Riva G, Vallerini D, Zanetti E, Potenza L, Forghieri F, Luppi M.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011043. doi: 10.4084/MJHID.2011.043. Epub 2011 Oct 24.

50.

May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery?

Potenza L, Barozzi P, Rossi G, Riva G, Vallerini D, Zanetti E, Quadrelli C, Morselli M, Forghieri F, Maccaferri M, Paolini A, Marasca R, Narni F, Luppi M.

Transplantation. 2011 Nov 15;92(9):e49-51, author reply e51-2. doi: 10.1097/TP.0b013e3182339d1a. No abstract available.

PMID:
22027897

Supplemental Content

Loading ...
Support Center